These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 21088936

  • 1. Normal variants of bowel FDG uptake in dual-time-point PET/CT imaging.
    Toriihara A, Yoshida K, Umehara I, Shibuya H.
    Ann Nucl Med; 2011 Apr; 25(3):173-8. PubMed ID: 21088936
    [Abstract] [Full Text] [Related]

  • 2. Breast cancer with low FDG uptake: characterization by means of dual-time point FDG-PET/CT.
    Zytoon AA, Murakami K, El-Kholy MR, El-Shorbagy E, Ebied O.
    Eur J Radiol; 2009 Jun; 70(3):530-8. PubMed ID: 18395387
    [Abstract] [Full Text] [Related]

  • 3. Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system.
    Schmidt H, Brendle C, Schraml C, Martirosian P, Bezrukov I, Hetzel J, Müller M, Sauter A, Claussen CD, Pfannenberg C, Schwenzer NF.
    Invest Radiol; 2013 May; 48(5):247-55. PubMed ID: 23519008
    [Abstract] [Full Text] [Related]

  • 4. [Value of dual-time-point (18)F-fluorodeoxyglucose integrated positron emission and computed tomography in differentiation of malignant from benign gastrointestinal diseases].
    Xu XX, Cheng J, Xu WG, Dai D, Song XY, Ma WC, Zhu L, Zhu X.
    Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):364-8. PubMed ID: 22883458
    [Abstract] [Full Text] [Related]

  • 5. Clinical usefulness of dual-time FDG PET-CT in assessment of esophageal squamous cell carcinoma.
    Shum WY, Hsieh TC, Yeh JJ, Chen JH, Su CC, Liang JA, Kao CH.
    Eur J Radiol; 2012 May; 81(5):1024-8. PubMed ID: 21458941
    [Abstract] [Full Text] [Related]

  • 6. Metformin discontinuation less than 72 h is suboptimal for F-18 FDG PET/CT interpretation of the bowel.
    Lee SH, Jin S, Lee HS, Ryu JS, Lee JJ.
    Ann Nucl Med; 2016 Nov; 30(9):629-636. PubMed ID: 27392947
    [Abstract] [Full Text] [Related]

  • 7. Influence of bowel preparation before 18F-FDG PET/CT on physiologic 18F-FDG activity in the intestine.
    Soyka JD, Strobel K, Veit-Haibach P, Schaefer NG, Schmid DT, Tschopp A, Hany TF.
    J Nucl Med; 2010 Apr; 51(4):507-10. PubMed ID: 20237041
    [Abstract] [Full Text] [Related]

  • 8. Dual-time-point 18F-FDG PET for the evaluation of gallbladder carcinoma.
    Nishiyama Y, Yamamoto Y, Fukunaga K, Kimura N, Miki A, Sasakawa Y, Wakabayashi H, Satoh K, Ohkawa M.
    J Nucl Med; 2006 Apr; 47(4):633-8. PubMed ID: 16595497
    [Abstract] [Full Text] [Related]

  • 9. Effects of blood glucose level on FDG uptake by liver: a FDG-PET/CT study.
    Kubota K, Watanabe H, Murata Y, Yukihiro M, Ito K, Morooka M, Minamimoto R, Hori A, Shibuya H.
    Nucl Med Biol; 2011 Apr; 38(3):347-51. PubMed ID: 21492783
    [Abstract] [Full Text] [Related]

  • 10. FDG uptake in brown adipose tissue-a brief report on brown fat with FDG uptake mechanisms and quantitative analysis using dual-time-point FDG PET/CT.
    Esen Akkas B, Gökaslan D, Güner L, Ilgin Karabacak N.
    Rev Esp Med Nucl; 2011 Apr; 30(1):14-8. PubMed ID: 20702004
    [Abstract] [Full Text] [Related]

  • 11. Performance of whole-body integrated 18F-FDG PET/MR in comparison to PET/CT for evaluation of malignant bone lesions.
    Eiber M, Takei T, Souvatzoglou M, Mayerhoefer ME, Fürst S, Gaertner FC, Loeffelbein DJ, Rummeny EJ, Ziegler SI, Schwaiger M, Beer AJ.
    J Nucl Med; 2014 Feb; 55(2):191-7. PubMed ID: 24309383
    [Abstract] [Full Text] [Related]

  • 12. Adrenal masses: the value of additional fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) in differentiating between benign and malignant lesions.
    Okada M, Shimono T, Komeya Y, Ando R, Kagawa Y, Katsube T, Kuwabara M, Yagyu Y, Kumano S, Imaoka I, Tsuchiya N, Ashikaga R, Hosono M, Murakami T.
    Ann Nucl Med; 2009 Jun; 23(4):349-54. PubMed ID: 19340526
    [Abstract] [Full Text] [Related]

  • 13. Aortic 18F-FDG PET/CT uptake pattern at 60 min (early) and 180 min (delayed) acquisition in a control population: a visual and semiquantitative comparative analysis.
    Martínez-Rodríguez I, Del Castillo-Matos R, Quirce R, Banzo I, Jiménez-Bonilla J, Martínez-Amador N, Ibáñez-Bravo S, Lavado-Pérez C, Bravo-Ferrer Z, Carril JM.
    Nucl Med Commun; 2013 Sep; 34(9):926-30. PubMed ID: 23797272
    [Abstract] [Full Text] [Related]

  • 14. A positron emission tomography/computed tomography (PET/CT) evaluation of asymptomatic abdominal aortic aneurysms: another point of view.
    Palombo D, Morbelli S, Spinella G, Pane B, Marini C, Rousas N, Massollo M, Cittadini G, Camellino D, Sambuceti G.
    Ann Vasc Surg; 2012 May; 26(4):491-9. PubMed ID: 22197524
    [Abstract] [Full Text] [Related]

  • 15. Dual-time-point F-18 FDG PET/CT for evaluation in patients with malignant lymphoma.
    Shinya T, Fujii S, Asakura S, Taniguchi T, Yoshio K, Alafate A, Sato S, Yoshino T, Kanazawa S.
    Ann Nucl Med; 2012 Oct; 26(8):616-21. PubMed ID: 22692457
    [Abstract] [Full Text] [Related]

  • 16. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.
    Zhang H, Wroblewski K, Liao S, Kampalath R, Penney BC, Zhang Y, Pu Y.
    Acad Radiol; 2013 Jan; 20(1):32-40. PubMed ID: 22999369
    [Abstract] [Full Text] [Related]

  • 17. Simultaneous positron emission tomography (PET) assessment of metabolism with ¹⁸F-fluoro-2-deoxy-d-glucose (FDG), proliferation with ¹⁸F-fluoro-thymidine (FLT), and hypoxia with ¹⁸fluoro-misonidazole (F-miso) before and during radiotherapy in patients with non-small-cell lung cancer (NSCLC): a pilot study.
    Vera P, Bohn P, Edet-Sanson A, Salles A, Hapdey S, Gardin I, Ménard JF, Modzelewski R, Thiberville L, Dubray B.
    Radiother Oncol; 2011 Jan; 98(1):109-16. PubMed ID: 21056487
    [Abstract] [Full Text] [Related]

  • 18. Comparison of the effect of positive and negative oral contrast agents on (18)F-FDG PET/CT scan.
    Sun XG, Huang G, Liu JJ, Wan LR.
    Hell J Nucl Med; 2009 Jan; 12(2):115-8. PubMed ID: 19675862
    [Abstract] [Full Text] [Related]

  • 19. Dual-time-point [18F]-FDG PET/CT in the diagnostic evaluation of suspicious breast lesions.
    Caprio MG, Cangiano A, Imbriaco M, Soscia F, Di Martino G, Farina A, Avitabile G, Pace L, Forestieri P, Salvatore M.
    Radiol Med; 2010 Mar; 115(2):215-24. PubMed ID: 20017002
    [Abstract] [Full Text] [Related]

  • 20. Dual-time-point 18F-FDG PET/CT versus dynamic breast MRI of suspicious breast lesions.
    Imbriaco M, Caprio MG, Limite G, Pace L, De Falco T, Capuano E, Salvatore M.
    AJR Am J Roentgenol; 2008 Nov; 191(5):1323-30. PubMed ID: 18941064
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.